Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The primary hypothesis of this trial is that the addition of short courses of clobetasol
propionate foam to etanercept monotherapy in subjects with moderate to severe plaque
psoriasis will yield greater efficacy compared with etanercept monotherapy, as measured by
PASI 75 at Week 12.